z-logo
Premium
Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca 2+ regulation prevail over changes in insulin content
Author(s) -
Anello Marcello,
Gilon Patrick,
Henquin JeanClaude
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702731
Subject(s) - tolbutamide , glibenclamide , diazoxide , medicine , endocrinology , insulin , islet , insulin oscillation , secretion , stimulation , chemistry , carbohydrate metabolism , biology , diabetes mellitus
To determine how pretreatment with sulphonylureas alters the β cell function, mouse islets were cultured (18–20 h) without (controls) or with (test) 0.01 μ M glibenclamide. Acute responses to glucose were then determined in the absence of glibenclamide. Test islets were insensitive to drugs (sulphonylureas and diazoxide) acting on K + ‐ATP channels, and their [Ca 2+ ] i was already elevated in the absence of stimulation. Insulin secretion was increased in the absence of glucose, and mainly stimulated between 0–10 instead of 7–20 m M glucose in controls. The maximum response was halved, but this difference disappeared after correction for the 45% decrease in the islet insulin content. The first phase of glucose‐induced insulin secretion was abrogated because of a paradoxical decrease of the high basal [Ca 2+ ] i in β cells. The second phase was preserved but occurred with little rise of [Ca 2+ ] i . These abnormalities did not result from alterations of glucose metabolism (NADPH fluorescence). In islets cultured with 50 μ M tolbutamide, glucose induced biphasic increases in [Ca 2+ ] i and insulin secretion. The decrease in the secretory response was matched by the decrease in insulin content (45%) except at maximal glucose concentrations. Islets pretreated with tolbutamide, however, behaved like those cultured with glibenclamide if tolbutamide was also present during the acute functional tests. In conclusion, treatment with a low glibenclamide concentration causes long‐lasting blockade of K + ‐ATP channels and rise of [Ca 2+ ] i in β cells. Glucose‐induced insulin secretion occurs at lower concentrations, is delayed and is largely mediated by a modulation of Ca 2+ action on exocytosis. It is suggested that glucose regulation of insulin secretion mainly depends on a K + ‐ATP channel‐independent pathway during in vivo sulphonylurea treatment.British Journal of Pharmacology (1999) 127 , 1883–1891; doi: 10.1038/sj.bjp.0702731

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom